T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects Meeting Abstract
| Authors: | Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; Liu, C.; Zappasodi, R.; Hollmann, T.; Lacouture, M.; Albrengues, J.; Egeblad, M.; Jedd, W.; Merghoub, T. |
| Abstract Title: | T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects |
| Meeting Title: | 32nd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 5 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Nov 8-12 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2017-11-07 |
| Start Page: | 87 |
| DOI: | 10.1186/s40425-017-0288-4 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: P330 -- Billel Gasmi's first name is misspelled on the original publication -- Xia Yang and Jedd Wolchok's first and last names are reversed on the original publication |
